Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04829604
Title ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ambrx, Inc.
Indications

breast cancer

Therapies

ARX-788

Age Groups: adult | senior
Covered Countries USA | FRA


No variant requirements are available.